Topics

Five deals reshaping the CDMO industry this year

09:22 EDT 5 Jul 2019 | BioPharma-Reporter

The major trend so far in 2019 is the willingness to deploy capital to expand services in the cell and gene therapy sector, and we outline the five most significant deals thus far.

Original Article: Five deals reshaping the CDMO industry this year

NEXT ARTICLE

More From BioPortfolio on "Five deals reshaping the CDMO industry this year"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...